Polaris Venture Partners - Home
Who We Are Portfolio News & Events careers
Visit DogPatch Labs

This content requires the Flash Plugin.
 
 
 
Our History   Our History
Founded in 1996, Polaris has backed and played a lead role in developing some of the most successful information technology and life sciences companies in the United States and Europe.
 
 
Our Strategy   Our Strategy
Diversification - across and within industries, and in stage - is the cornerstone of Polaris' investment strategy.
 
 
Our Team   Our Team
We have built an exceptional team of venture capitalists and technology executives with a broad range of investment and operating experience, the highest business standards, and a commitment to success.
 
Our Recruiting Resources   Our Recruiting Resources
Helping build first-rate management teams is a key commitment we make to the companies we back. Our on-staff team has recruited to our portfolio companies more than 50 executives for a wide range of positions without the use of an outside recruiter, from CEO to the director level.
 
  Polaris Stars
Polaris has backed many companies that have become stars in their fields.
 
Congratulations to these Polaris portfolio companies on their recent Public Offerings or Acquisitions:
 Free & Clear (Acquired by Inverness 9/21/09) | Sentillion (Acquired by Microsoft  2/2/10) | Ironwood Pharmaceuticals (IPO 2/2/10; NASDAQ: IRWD)|Alimera Sciences (IPO 4/21/10;  NASDAQ: ALIM) |LogMeIn (IPO 07/01/09; NASDAQ : LOGM)|170 Systems (acquired by Kofax plc 9/7/09)|
  Copyrights © Polaris Venture Partners, 2004. All rights reserved.
Contact Us Site Map

CONGRATULATIONS Alimera!

Alimera

Alimera Sciences Prices Initial Public Offering

ATLANTA, Apr 23, 2010 - Alimera Sciences, Inc. (Nasdaq:ALIM), ("Alimera") today announced that it priced its initial public offering of 6,550,000 shares of common stock at a price to the public of $11.00 per share on Wednesday, April 21, 2010.

Full Story

7/14/2010
Trevena completes $35M Series B financing

7/1/2010
Bind Biosciences, a biopharmaceutical company, has secured a $12.4 million series C-1 financing.

6/10/2010
Jarvi to join Sun Catalytix as startup's CTO

5/11/2010
Mintera gathers $1.65M financing round